title: Complete pathological response in a patient with metastatic esophageal cancer treated with a regimen of capecitabine, oxaliplatin and docetaxel: a case report.
authors.affiliation: New York University School of Medicine, New York, NY, USA, nagashree.seetharamu@nyumc.org.
authors.forename: Nagashree
authors.initials: N
authors.lastname: Seetharamu
authors.forename: Jonathan
authors.initials: J
authors.lastname: Melamed
authors.forename: George
authors.initials: G
authors.lastname: Miller
authors.forename: Heidrun
authors.initials: H
authors.lastname: Rotterdam
authors.forename: Tamas
authors.initials: T
authors.lastname: Gonda
authors.forename: Gerald
authors.initials: G
authors.lastname: Villanueva
authors.forename: Balazs
authors.initials: B
authors.lastname: Halmos
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077143:Docetaxel; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D043823:Taxoids / Q000008:administration & dosage
chemical_list: D009944:Organoplatinum Compounds; D043823:Taxoids; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000077143:Docetaxel; D000069287:Capecitabine; D005472:Fluorouracil